http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101462160-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-19 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
filingDate | 2012-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101462160-B1 |
titleOfInvention | Composition for Anti-Diabetes Using of Citrus Fermented by Lactice Acid Bacteria |
abstract | The present invention discloses an antidiabetic composition using a fermented product of citrus lactic acid bacteria. More specifically, the present invention relates to an antidiabetic composition comprising a fermented product of citrus Lactobacillus which shows a remarkable hypoglycemic activity when streptozotocin is administered to an animal in which diabetes is induced, and exhibits a markedly lowered blood glucose level in the glucose tolerance test . |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200128299-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200012236-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102097509-B1 |
priorityDate | 2012-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 334.